DK1121109T3 - Tofaset sammensætning med tramadol - Google Patents

Tofaset sammensætning med tramadol

Info

Publication number
DK1121109T3
DK1121109T3 DK99953856T DK99953856T DK1121109T3 DK 1121109 T3 DK1121109 T3 DK 1121109T3 DK 99953856 T DK99953856 T DK 99953856T DK 99953856 T DK99953856 T DK 99953856T DK 1121109 T3 DK1121109 T3 DK 1121109T3
Authority
DK
Denmark
Prior art keywords
active substance
weight
tramadol
phase composition
release rate
Prior art date
Application number
DK99953856T
Other languages
English (en)
Inventor
Udo Hahn
Walter Wimmer
Bianca Broegmann
Christof Spitzley
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of DK1121109T3 publication Critical patent/DK1121109T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK99953856T 1998-10-15 1999-10-15 Tofaset sammensætning med tramadol DK1121109T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE29818454U DE29818454U1 (de) 1998-10-15 1998-10-15 Opioid-Analgetikum

Publications (1)

Publication Number Publication Date
DK1121109T3 true DK1121109T3 (da) 2006-10-02

Family

ID=8063985

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99953856T DK1121109T3 (da) 1998-10-15 1999-10-15 Tofaset sammensætning med tramadol

Country Status (10)

Country Link
EP (1) EP1121109B8 (da)
JP (1) JP5414956B2 (da)
AT (1) ATE327742T1 (da)
AU (1) AU1039400A (da)
CY (1) CY1105168T1 (da)
DE (2) DE29818454U1 (da)
DK (1) DK1121109T3 (da)
ES (1) ES2267301T3 (da)
PT (1) PT1121109E (da)
WO (1) WO2000021520A2 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US9820982B2 (en) 2001-07-06 2017-11-21 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
BR0210855A (pt) 2001-07-06 2006-10-24 Penwest Pharmaceuticals Compan Método de fabricação de formulações de liberação prolongada
CA2478515C (en) 2002-04-05 2010-09-28 Purdue Pharma Pharmaceutical preparation containing oxycodone and naloxone
JP2006328053A (ja) * 2005-04-26 2006-12-07 Takeda Chem Ind Ltd モルヒネ含有医薬
EP2002828B1 (en) 2006-03-30 2019-08-07 Nippon Zoki Pharmaceutical Co. Ltd. Solid pharmaceutical preparation
JP2011511782A (ja) 2008-02-12 2011-04-14 アボット・ラボラトリーズ 長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
EP2555756B1 (en) * 2010-04-07 2018-08-22 Lupin Limited Controlled release pharmaceutical compositions of tapentadol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5645858A (en) * 1994-10-06 1997-07-08 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
KR100341829B1 (ko) * 1996-03-08 2002-08-22 니코메드 덴마크 에이/에스 방출특성이변형된다-유니트투여량조성물
DE19710008A1 (de) * 1997-03-12 1998-09-17 Basf Ag Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung

Also Published As

Publication number Publication date
WO2000021520A2 (de) 2000-04-20
DE29818454U1 (de) 1999-01-14
WO2000021520A3 (de) 2000-08-03
PT1121109E (pt) 2006-09-29
CY1105168T1 (el) 2010-03-03
EP1121109A2 (de) 2001-08-08
DE59913493D1 (de) 2006-07-06
EP1121109B1 (de) 2006-05-31
JP2002527384A (ja) 2002-08-27
ES2267301T3 (es) 2007-03-01
ATE327742T1 (de) 2006-06-15
JP5414956B2 (ja) 2014-02-12
EP1121109B8 (de) 2006-07-19
AU1039400A (en) 2000-05-01

Similar Documents

Publication Publication Date Title
WO2003072025A3 (en) Modified release formulations of at least one form of tramadol
AP1526A (en) Sertraline salts and sustained-release dosage forms of sertraline.
WO2001085257A3 (en) Opioid antagonist compositions and dosage forms
BR9908545A (pt) Derivado de piperidina, processo para a preparação do mesmo, composto, processo para a preparação do mesmo, e, composição farmacêutica
ES2058111T3 (es) Composicion de liberacion controlada de dihidrocodeina.
BR9916790A (pt) Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente
NO20022264L (no) Farmasoytisk blanding inneholdende tolterodin, samt anvendelse derav
CA2339991A1 (en) Microemulsions as solid dosage forms for oral administration
MY127797A (en) 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol-containing pharmaceutical composition with slow release of active indgredient
TR200100889T2 (tr) Disfosfonik asit içeren terkipler
AP1849A (en) Dosage regimen and pharmaceutical composition for emergency contraception
SG162605A1 (en) Pharmaceutical compositions
ATE327742T1 (de) Zweiphasige zusammensetzung mit tramadol
CA2415154A1 (en) Modified release formulations of selective serotonin re-uptake inhibitors
BR0207297A (pt) Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo
WO2001051055A3 (en) Pharmaceutical compositions containing steroidal structures and uses thereof
CA2348395A1 (en) Compositions comprising a mixture of bioflavonols
WO2004096181A3 (en) Solid dosage form comprising desmopressin
ZA202404160B (en) Oral solution containing lisdexamfetamine and process for the preparation thereof
YU20050411A (sh) Komopzicije oksikodona sa kontrolisanim oslobadanjem
WO2002081462A8 (en) Aminoflavone compounds, compositions, and methods of use thereof
AP2002002662A0 (en) Sertraline salts and sustained-release dosage forms of sertraline
YU20050409A (sh) Kompozicije oksikodona sa kontrolisanim oslobađanjem
SE0000782D0 (sv) Pharmaceutical formulation and its use
TH20304A (th) สูตรปลดปล่อยที่ควบคุมซึ่งมีทรามาดอล